Men clinical trials at UC Health
2 research studies open to new patients
Study of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception
open to eligible people ages 18-50
The long term objective is to develop a gel to be used as a male contraceptive.
open to eligible males ages 18-50
This is a Phase IIa multicenter, double-blind, placebo-controlled study in healthy men to evaluate the spermatogenesis suppression after oral administration of Dimethandrolone Undecanoate (DMAU) alone or with Levonorgestrel (LNG) for 12 weeks versus placebo alone.